A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2011
12/14/2011	CN102274272A 三萜组合物和它们的使用方法 Triterpenoids compositions and methods for their use
12/14/2011	CN102274266A 接骨木果油的超临界二氧化碳萃取方法 Supercritical carbon dioxide extraction method elderberry oil
12/14/2011	CN102274239A 低聚异麦芽糖用于抑制血管发生的用途 Isomaltooligosaccharide for inhibiting angiogenesis
12/14/2011	CN102274238A 一种治疗胰腺癌的药物组合物 A method of treating pancreatic cancer in a pharmaceutical composition
12/14/2011	CN102274237A 黄酮类化合物的新用途 New uses of flavonoids
12/14/2011	CN102274232A Application of adenosine receptor A1 antagonist in preparing medicine
12/14/2011	CN102274230A Kit突变形式的抑制剂 Kit inhibitors of mutant forms of
12/14/2011	CN102274220A 索拉菲尼在制备逆转肿瘤多药耐药性的药物中的应用 Sorafenib application in the preparation of the reversal of multidrug resistance in cancer medicine
12/14/2011	CN102274210A Applications of ineupatorolide B in preparation of antitumor drugs
12/14/2011	CN102274193A 一种改进的载植物多酚类化合物缓释微球的制备方法 An improved plant polyphenolic compounds contained in sustained release microsphere preparation
12/14/2011	CN102274190A 一种注射用紫杉醇白蛋白亚微粒及其制备方法 An injection of paclitaxel albumin submicron its preparation method
12/14/2011	CN102274186A 一种用于抗癌的镜像多肽脂质纳米制剂 Mirroring peptide lipid nano-formulations for cancer
12/14/2011	CN102274185A 抗肿瘤pH敏感脂质体、其冻干粉针制剂及它们的制备方法 Anti-tumor pH-sensitive liposomes, lyophilized powder for injection formulations and methods for their preparation
12/14/2011	CN102274181A 一种多西他赛脂质微球注射液及其制备方法 A multi-docetaxel lipid microsphere injection and its preparation method
12/14/2011	CN102274171A 一种奥沙利铂注射剂 One kind of oxaliplatin injection
12/14/2011	CN102274163A 一种姜黄素纳米胶束制剂及其制备方法 One kind of curcumin micelles and its preparation method
12/14/2011	CN102008518B Seabuckthorn seed oil liposome preparation process
12/14/2011	CN101912529B 一种超声提取多穗金粟兰总黄酮的方法 An ultrasonic extraction method multiple ear Chloranthus total flavonoids
12/14/2011	CN101905017B Method for preparing chitosan nanoparticles
12/14/2011	CN101829052B 紫杉烷类化合物的自乳化制剂及其制备方法 Self-emulsifying formulation and preparation of taxanes
12/14/2011	CN101822635B 组合物在制备原位液晶血管栓塞剂中的应用 The composition used in the preparation of in-situ liquid embolization agent
12/14/2011	CN101810827B 一种治疗乳癖的中药制剂 A treatment of Chinese medicine Rubi
12/14/2011	CN101805408B 抗肿瘤溶栓双效嵌合蛋白及其制备方法和应用 Anti-tumor effect of thrombolytic double chimeric protein and its preparation method and application
12/14/2011	CN101735237B 三聚桔霉素类化合物及其制备方法和用途 Trimeric Citrinin compounds and preparation and use
12/14/2011	CN101724018B 2-(2-甲基丙烯酰胺基三甘氨酰基)氨基丙二酸酯及其制备方法、应用 2- (2-acrylamide-three glycyl) amino malonate and its preparation method, application
12/14/2011	CN101716352B 抗中期因子反义寡核苷酸纳米制剂及其制备与应用 Anti-midkine antisense oligonucleotides and its preparation and application of nano
12/14/2011	CN101695513B 一种具有抗肿瘤作用的组合物及其应用 A composition with anti-tumor effect and its application
12/14/2011	CN101643466B 一种高纯度的表没食子儿茶素没食子酸酯及其制备方法 A high-purity Epigallocatechin gallate and its preparation method
12/14/2011	CN101642568B 一种红景天组合物 Rhodiola one kind of composition
12/14/2011	CN101636154B Task-1和task-3离子通道抑制剂 Task-1 and task-3 ion channel inhibitors
12/14/2011	CN101623420B 一种治疗良性肿瘤的中药敷贴膏 A treatment for benign medicine applicator cream
12/14/2011	CN101585868B 一种麒麟菜天然色素糖蛋白的提取方法及其应用 A method of extracting natural pigment Eucheuma glycoprotein and its application
12/14/2011	CN101514354B 一种海参多肽及其制备方法与应用 Sea cucumber peptide and its preparation method and application
12/14/2011	CN101505755B 抗癌药耐性克服剂 Overcoming resistance to anticancer drug agent
12/14/2011	CN101486973B 一种合成苦马豆素的棘豆埃里格孢菌及其制备方法和应用 A synthetic Swainsonine of Oxytropis Ehrig cinerea and its preparation method and application
12/14/2011	CN101472930B 用作PI3K抑制剂的噻吩并[3,2-d]嘧啶的衍生物 Used as PI3K inhibitors thieno [3,2-d] pyrimidine derivatives
12/14/2011	CN101461948B 一种叶酸介导的5-氟尿嘧啶白蛋白大分子前体药物及其制备方法和应用 5-fluorouracil albumin macromolecular prodrug and its preparation method and application of a folate-mediated
12/14/2011	CN101448840B 四氢吡啶并噻吩并嘧啶化合物及其使用方法 Tetrahydropyrido thieno pyrimidine compounds and methods of use
12/14/2011	CN101396347B 一种重组人血管内皮抑制素缓释微球的制备方法 A recombinant human endostatin release microsphere preparation
12/14/2011	CN101328475B 核酸分子nrn1sr1及其在制备抗癌药物中的应用 Nrn1sr1 nucleic acid molecule and its application in the preparation of anti-cancer drugs
12/14/2011	CN101245109B 一种聚乙二醇单修饰的重组人粒细胞集落刺激因子突变体及其制备方法 One polyethylene glycol mono-modified recombinant human granulocyte colony-stimulating factor mutant and its preparation method
12/14/2011	CN101244097B 包含有藤黄的酸性活性成分的蜡质骨架缓释剂 Waxy release agent containing the skeleton of acidic active ingredient Garcinia
12/14/2011	CN101209247B 一种结肠靶向制剂的制备方法 Preparation of a colon targeting agents
12/14/2011	CN101167765B 结肠靶向给药软胶囊及其制备方法 Colon targeted drug delivery soft capsule and its preparation method
12/14/2011	CN101108001B 保健功能食品 Health functional food
12/13/2011	US8076490 Epothilones C, D, E, and F, preparation and compositions
12/13/2011	US8076488 Antiproliferative agents; angiogenesis inhibitors; anticancer agents
12/13/2011	US8076367 Benzimidazolylidene propane-1,3-dione derivative or salt thereof
12/13/2011	US8076347 (-)-(2S,4S)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl)cytosine (OddC); "L"-nucleoside that exhibits anti-tumor activity; anticarcinogenic agent for non-small cell lung cancer, colon, breast, prostate, ovarian, CNS, renal, and lymphoma cancer, leukemia, melanoma
12/13/2011	US8076337 Antitumoral derivatives of ET-743
12/13/2011	US8076335 Processes of making pharmaceutical formulations of antineoplastic agents
12/13/2011	US8076284 Analogues of antimicrobial and anticancer peptide synthesized and produced from Gaegurin 5
12/13/2011	US8076132 Dendritic cell tumor injection (DCTI) therapy
12/13/2011	US8076098 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/13/2011	US8076096 Alteration of cell membrane with FasL
12/13/2011	US8076066 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy
12/13/2011	US8075923 Use of hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4)-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
12/13/2011	US8075917 Composition for solubilization of paclitaxel and preparation method thereof
12/13/2011	US8075913 Method of producing a cationic liposomal preparation comprising a lipophilic compound
12/13/2011	US8075892 Treatment with anti-ErbB2 antibodies
12/13/2011	CA2656005C Chemotherapeutic compounds for selectively targeting tumor cells with fr type receptors
12/13/2011	CA2554024C A stable solution containing beside water either (6s)-sodium-folinate or (6s)-potassium-folinate in an amount from 2% by weight to 6% by weight
12/13/2011	CA2492287C Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
12/13/2011	CA2476247C Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
12/13/2011	CA2476008C Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
12/13/2011	CA2450448C Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/08/2011	WO2011153514A2 The use of inhibitors of bruton's tyrosine kinase (btk)
12/08/2011	WO2011153509A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
12/08/2011	WO2011153383A1 Methods of treating platinum-resistant recurrent ovarian cancer with 4-iodo-3-nitrobenzamide in combination with an anti-metabolite and a platinum compound
12/08/2011	WO2011153382A1 Methods of treating platinum-sensitive recurrent ovarian cancer with 4-iodo-3-nitrobenzamide in combination with an anti-metabolite and platinum compound
12/08/2011	WO2011153365A1 Phosphaplatins and their use for treatment of cancers
12/08/2011	WO2011153331A2 Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo
12/08/2011	WO2011153287A2 Materials and methods for diagnosing and predicting the course of prostate cancer
12/08/2011	WO2011153226A2 Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof
12/08/2011	WO2011153221A1 Solid state forms of ixabepilone
12/08/2011	WO2011153199A1 Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone
12/08/2011	WO2011153197A1 Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
12/08/2011	WO2011153192A2 Cytochrome p450 inhibitors and uses thereof
12/08/2011	WO2011153157A2 Benzoquinolone inhibitors of vmat2
12/08/2011	WO2011153010A1 Methods of treatment of pancreatic cancer
12/08/2011	WO2011153009A1 Methods of treating bladder cancer
12/08/2011	WO2011152884A2 14 gene signature distinguishes between multiple myeloma subtypes
12/08/2011	WO2011152554A1 Method for producing tumor cell
12/08/2011	WO2011152525A1 Antibody and use thereof
12/08/2011	WO2011152516A1 Anti-tumor agent combined with kinase inhibitor
12/08/2011	WO2011152515A1 Antitumor agent containing indole compound
12/08/2011	WO2011152508A1 Optically active dibenzylamine derivative, and manufacturing method for same
12/08/2011	WO2011152485A1 Novel 4,5-fused pyrimidine derivative
12/08/2011	WO2011152351A1 Purinone derivative
12/08/2011	WO2011152330A1 Soybean protein hydrolysate-containing antioxidant and use thereof
12/08/2011	WO2011152297A1 Solid dispersion comprising triazole compound
12/08/2011	WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
12/08/2011	WO2011151978A1 Fluorescent dye material and use thereof
12/08/2011	WO2011151822A1 3-substituted vinylboronates and uses thereof
12/08/2011	WO2011151423A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors
12/08/2011	WO2011151412A1 Novel anti-cmet antibody
12/08/2011	WO2011151403A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1
12/08/2011	WO2011151399A1 Rhenium complexes and their pharmaceutical use.
12/08/2011	WO2011151251A1 New ccr2 antagonists

1 ... 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 ... 2211